In line with these findings in murine models, Lührs et al. 62 reported that n‐butyrate treatment of patients suffering from ulcerative colitis resulted in reduced NF‐κB activation in lamina propria macrophages, which correlated with amelioration of intestinal inflammation. Here, NFKB1 is linked to ulcerative colitis.